SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Biotie Therapies Corp.
Start Date
September 1, 2016
End Date
January 18, 2018
Administered By
Neurology, Movement Disorders
Awarded By
Biotie Therapies Corp.
Start Date
September 1, 2016
End Date
January 18, 2018